On-Demand Webinars

  1. How To Build Your AI Governance Guardrails 6/18/2026

    Establish robust artificial intelligence governance with ISO 42001 standards by mapping operational risks, assigning accountable owners, and aligning with emerging regulatory requirements.

  2. Data-Driven Strategies To De-Risk OSD Development 6/17/2026

    Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

  3. Solving Formulation Challenges Across Modalities 6/15/2026

    Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.

  4. Unlocking Scalable Oligonucleotide Manufacturing, Driving Commercial Success With Asymchem's Multi-Platform Solutions 6/11/2026

    Explore how advanced synthesis platforms, integrated CMC strategies, and scalable technologies are addressing complexity, cost, and regulatory demands.

  5. Using Residual DNA Quantification Data To De-Risk mAb Development 6/11/2026

    Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

  6. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

  7. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  8. Efficient mAb Development With A Flexible Purification Toolkit 6/4/2026

    Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

  9. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

  10. How Solid-State Science Solves Your Toughest API Challenges 6/3/2026

    Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.